0001562180-21-005744.txt : 20210902 0001562180-21-005744.hdr.sgml : 20210902 20210902160750 ACCESSION NUMBER: 0001562180-21-005744 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210831 FILED AS OF DATE: 20210902 DATE AS OF CHANGE: 20210902 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Burke Steven Keith CENTRAL INDEX KEY: 0001619834 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36352 FILM NUMBER: 211233308 MAIL ADDRESS: STREET 1: 82 WILLIS ROAD CITY: SUDBURY STATE: MA ZIP: 01776 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Akebia Therapeutics, Inc. CENTRAL INDEX KEY: 0001517022 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208756903 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-871-2098 MAIL ADDRESS: STREET 1: 245 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2021-08-31 false 0001517022 Akebia Therapeutics, Inc. AKBA 0001619834 Burke Steven Keith C/O AKEBIA THERAPEUTICS, INC 245 FIRST STREET CAMBRIDGE MA 02142 false true false false SVP, Chief Medical Officer Common Stock 2021-08-31 4 S false 1042.00 2.83 D 171219.00 D This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on August 30, 2019. Includes 1,500 shares of the Issuer's common stock purchased on June 30, 2021 under the Issuer's 2014 Amended and Restated Employee Stock Purchase Plan. /s/ Nicole R. Hadas, attorney-in-fact for Steven K. Burke 2021-09-02